INSIGHTS ON DRUG DEVELOPMENT
-
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
Creative Chromatography Solutions For Complex Small Molecules
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
-
How AI Is Reshaping Pharmacovigilance: Key Takeaways From The New CIOMS Report
Deploying AI in pharmacovigilance requires risk-based oversight, human accountability, transparent governance, and representative performance testing.
-
Easy Automation For Cell-Based Assays
Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
-
Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids3/24/2025
3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.
-
Optical Microscopy For Process Monitoring And Product Characterization3/9/2026
Modern optical microscopy reveals cellular activity and material quality with exceptional clarity. See how tailored, feature‑rich imaging systems help researchers generate high‑value data.
-
Engineering The Future Of Lipsomal Drug Delivery5/14/2025
Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.
-
Producing Quality APIs At Scale5/7/2026
Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.
-
qPCR Amplification Of Human Gastrointestinal Samples6/15/2026
Residual inhibitors in GI-derived DNA can hinder qPCR performance. An optimized approach improves inhibitor tolerance and enables earlier target detection, delivering more reliable amplification.
DRUG DEVELOPMENT SOLUTIONS
-
Precise optics, fluidic transfer, and assay flexibility on one integrated microplate reader.
-
Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.
-
Boost genomics productivity with a solution built for speed, precision, and high throughput with extended walkaway times and reliable performance that helps teams get more done.
-
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
The most powerful and versatile rheometer for your laboratory.